Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions

Ticagrelor-based dual antiplatelet therapy (DAPT) provides potent antiplatelet inhibition but may increase the bleeding risk in Asian populations. We investigated the influence of early ticagrelor dose reduction (120 mg) on clinical outcomes in Korean patients undergoing percutaneous coronary interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yonggu, Shin, Jeong-Hun, Seo, Suk Min, Choi, Ik Jun, Lee, Jong-Young, Lee, Jun-Won, Park, Mahn-Won, Kang, Tae Soo, Choi, Woong Gil, Jeon, Ki-Hyun, Lim, Hong-Seok, Joo, Hyung Joon, Rhee, Sang Jae, Seo, Jae-Bin, Park, Myung Soo, Park, Sang-Ho, Lim, Young-Hyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509174/
https://www.ncbi.nlm.nih.gov/pubmed/37726368
http://dx.doi.org/10.1038/s41598-023-42655-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509174/
https://www.ncbi.nlm.nih.gov/pubmed/37726368
http://dx.doi.org/10.1038/s41598-023-42655-4

Ejemplares similares